Giaccari, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 4.208
EU - Europa 3.919
AS - Asia 1.846
SA - Sud America 401
AF - Africa 33
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.426
Nazione #
US - Stati Uniti d'America 4.157
DE - Germania 802
SG - Singapore 644
PL - Polonia 639
CN - Cina 622
IT - Italia 579
SE - Svezia 529
BR - Brasile 377
FR - Francia 302
UA - Ucraina 277
IE - Irlanda 198
GB - Regno Unito 197
ID - Indonesia 121
FI - Finlandia 118
IN - India 108
TR - Turchia 97
RU - Federazione Russa 86
KR - Corea 43
NL - Olanda 36
VN - Vietnam 34
AT - Austria 32
HK - Hong Kong 32
CA - Canada 28
BE - Belgio 27
AE - Emirati Arabi Uniti 24
JP - Giappone 18
IR - Iran 17
ES - Italia 16
CH - Svizzera 15
AU - Australia 14
MX - Messico 13
IQ - Iraq 12
RO - Romania 12
AR - Argentina 10
MA - Marocco 10
PK - Pakistan 10
SA - Arabia Saudita 10
BD - Bangladesh 8
GR - Grecia 8
MY - Malesia 8
CZ - Repubblica Ceca 7
DK - Danimarca 6
LT - Lituania 6
AZ - Azerbaigian 5
BG - Bulgaria 4
BY - Bielorussia 4
EG - Egitto 4
IL - Israele 4
KG - Kirghizistan 4
NG - Nigeria 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
KE - Kenya 3
KH - Cambogia 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
BJ - Benin 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TH - Thailandia 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
CM - Camerun 1
CO - Colombia 1
GE - Georgia 1
GY - Guiana 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VA - Santa Sede (Città del Vaticano) 1
Totale 10.426
Città #
Chandler 708
Warsaw 553
Singapore 350
Ashburn 334
Fairfield 215
Dublin 195
Wilmington 183
Rome 165
Houston 159
San Mateo 156
Jacksonville 147
Milan 123
Jakarta 118
Seattle 115
New York 107
Nanjing 106
Woodbridge 91
Ann Arbor 84
Kraków 79
Izmir 74
Boston 68
Princeton 67
Los Angeles 65
The Dalles 65
Dearborn 62
Cambridge 54
Moscow 54
Beijing 50
Bremen 49
Hefei 45
Chicago 43
Hangzhou 43
Redwood City 42
Helsinki 40
Frankfurt am Main 39
Cattolica 37
London 37
Seoul 37
Marseille 35
São Paulo 35
Mountain View 34
Munich 31
Nanchang 31
Falls Church 29
Nuremberg 29
Nürnberg 28
Boardman 26
Brussels 26
North Bergen 26
Vienna 24
Lawrence 23
Lancaster 22
Redmond 22
Düsseldorf 21
Shanghai 21
Busto Arsizio 20
Kunming 18
Norwalk 18
Pune 17
San Diego 17
Sharjah 17
Tianjin 17
Turku 17
Andover 16
Augusta 16
Fremont 16
Hong Kong 16
Jiaxing 16
Shenyang 16
Wayne 16
Dong Ket 15
Lappeenranta 15
Belo Horizonte 14
Brescia 14
Guangzhou 14
Zhengzhou 14
Amsterdam 13
Detroit 13
Hebei 13
Lauterbourg 13
Basking Ridge 12
Bexley 11
Blackpool 11
Bologna 11
Phoenix 11
Portsmouth 11
Rio de Janeiro 11
Tappahannock 11
Changsha 10
Curitiba 10
Kish 10
Manchester 10
Toronto 10
Washington 10
Berlin 9
Brooklyn 9
Buffalo 9
Hanoi 9
Riyadh 9
San Francisco 9
Totale 6.016
Nome #
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 324
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus. 308
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 281
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial 281
Comment on: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 245
Sotagliflozin, the first dual SGLT inhibitor: Current outlook and perspectives 11 Medical and Health Sciences 1103 Clinical Sciences 228
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes 203
High-normal TSH values in obesity depends on adipose tissue rather than insulin resistance 188
In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance 176
METABOLIC SYNDROME IN TRANSPLANT PATIENTS: AN UPDATING POINT OF VIEW 163
D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation 147
A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT 147
Removal of Duodenum Elicits GLP-1 Secretion 144
β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans. 141
Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy 140
The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach 137
The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? 134
Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? 130
Hypovitaminosis D Is Associated with Liver Insulin Resistance in Obese Subjects 128
25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity 125
Metabolic syndrome in transplant patients: an academic or a health burden? 122
β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity 122
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial 120
Endocrine and Metabolic Insights from Pancreatic Surgery 119
Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes 118
Will vitamin D reduce insulin resistance? Still a long way to go 115
Advancing Diabetes Research: a novel islet isolation method from living donors. 114
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 111
High-normal TSH values in obesity: is it insulin resistance or adipose tissue's guilt? 110
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 110
Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives 104
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 104
β α-Cell glucose sensitivity is linked to insulin/glucagon bihormonal cells in nondiabetic humans 103
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study 101
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus 101
Vitamin D deficiency: a new risk factor for type 2 diabetes? 99
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: Evidence to date 98
Insulin resistance alters islet morphology in nondiabetic humans 97
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 97
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 96
Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes: Comment to Kayaniyil et al. 94
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences 93
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 92
Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports 87
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 86
Bile modulates secretion of incretins and insulin: a study on human extrahepatic cholestasis 85
Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment 83
Postoperative hyperglycemia affects survival after gastrectomy for cancer: A single-center analysis using propensity score matching 83
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 81
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 79
The Interplay between Immune System and Microbiota in Diabetes 78
Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis 77
β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging Rats 75
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. 75
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 74
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 72
Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results 72
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation 71
Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation 68
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study 68
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 68
A systematic comparison of protocols for recovery of high-quality rna from human islets extracted by laser capture microdissection 68
Self-monitoring of blood glucose: guideline 1 application rather than utilization restrictions on testing strips has potential to reduce diabetic healthcare costs in Italy 67
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function 66
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features 66
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. 66
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 65
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. 65
Peroxiredoxin 6, a novel player in the pathogenesis of diabetes 65
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia 64
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes 63
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice 62
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2 62
Management of diabetes in older adults 61
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes 60
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 60
Self-management in patients with type 2 diabetes: Group-based versus individual education. A systematic review with meta-analysis of randomized trails 60
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report 59
SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice 59
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 57
Genetic disruption of SOD1 gene causes glucose intolerance and impairs β-cell function 56
In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study 55
Nuclear export of FoxO1 is associated with ERK signaling in β-cells lacking insulin receptors 55
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 55
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes 54
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes 54
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 54
Evaluation of guidelines on diabetes medication 52
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 50
Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity. 49
Beta-cell function and glucose metabolism in patients with chronic pancreatitis 48
Beta-cell function and glucose metabolism in patients with chronic pancreatitis 47
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials 47
Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release 46
Publish and perish 46
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: the Italian Titration Approach Study (ITAS) 46
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population 45
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus 44
Expression of the two insulin receptor isoforms is not altered in the skeletal muscle and liver of diabetic rats. 42
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010" 41
Totale 9.773
Categoria #
all - tutte 48.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 0 0 0 0 0 0 0 0 74
2020/2021913 49 80 84 90 130 62 91 28 95 46 117 41
2021/20221.100 102 69 50 76 78 36 65 199 40 71 129 185
2022/20231.995 230 233 161 324 115 241 58 173 255 48 83 74
2023/20241.206 56 290 47 52 63 157 113 82 26 62 95 163
2024/20252.607 78 74 201 110 155 93 105 196 387 306 600 302
Totale 10.623